KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Raw Materials (2021 - 2023)

Ginkgo Bioworks Holdings (DNA) has disclosed Raw Materials for 3 consecutive years, with $2.3 million as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Raw Materials rose 182.73% year-over-year to $2.3 million, compared with a TTM value of $2.3 million through Mar 2023, up 182.73%, and an annual FY2022 reading of $1.6 million, up 2384.38% over the prior year.
  • Raw Materials was $2.3 million for Q1 2023 at Ginkgo Bioworks Holdings, up from $1.6 million in the prior quarter.
  • Across five years, Raw Materials topped out at $2.3 million in Q1 2023 and bottomed at $64000.0 in Q4 2021.
  • Average Raw Materials over 3 years is $1.1 million, with a median of $863000.0 recorded in 2022.
  • Peak annual rise in Raw Materials hit 2384.38% in 2022, while the deepest fall reached 54.71% in 2022.
  • Year by year, Raw Materials stood at $64000.0 in 2021, then surged by 2384.38% to $1.6 million in 2022, then soared by 42.08% to $2.3 million in 2023.
  • Business Quant data shows Raw Materials for DNA at $2.3 million in Q1 2023, $1.6 million in Q4 2022, and $1.3 million in Q3 2022.